Clinical Trial Update: Pegintron Induction Therapy in HCV Non-Responders [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting the completion of Pegintron induction therapy for hepatitis C in patients who did not respond to prior treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)

Snippet

Sponsor: Foundation for Liver Research | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED